BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32699114)

  • 1. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus.
    Oyagüez I; Merino-Torres JF; Brito M; Bellido V; Cardona-Hernandez R; Gomez-Peralta F; Morales-Perez F
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32699114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost Analysis of FreeStyle Libre
    Oyagüez I; Gómez-Peralta F; Artola S; Carrasco FJ; Carretero-Gómez J; García-Soidan J; Gómez-Huelgas R; Merino-Torres JF; Pérez A
    Diabetes Ther; 2021 Sep; 12(9):2329-2342. PubMed ID: 33948909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.
    Hellmund R; Weitgasser R; Blissett D
    Diabetes Res Clin Pract; 2018 Apr; 138():193-200. PubMed ID: 29410149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness, safety and costs of the FreeStyle Libre glucose monitoring system for children and adolescents with type 1 diabetes in Spain: a prospective, uncontrolled, pre-post study.
    González-Pacheco H; Rivero-Santana A; Ramallo-Fariña Y; Valcárcel-Nazco C; Álvarez-Pérez Y; García-Pérez L; García-Bello MA; Perestelo-Pérez L; Serrano-Aguilar P;
    BMJ Open; 2023 Dec; 13(12):e071334. PubMed ID: 38097245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis.
    Blissett R; Blissett D; Levrat-Guillen F; Deshmukh H; Wilmot EG; Ryder REJ; Walton C; Sathyapalan T
    BMJ Open Diabetes Res Care; 2022 Mar; 10(2):. PubMed ID: 35346970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.
    Chaugule S; Graham C
    J Med Econ; 2017 Nov; 20(11):1128-1135. PubMed ID: 28745578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL; Willis WD; Foos V
    Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
    Giménez M; Elías I; Álvarez M; Quirós C; Conget I
    Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile.
    Palacios A; Rodriguez Cairoli F; Balan D; Balmaceda C; Augustovski F; Pichon-Riviere A; Bardach A
    Expert Rev Pharmacoecon Outcomes Res; 2023 Mar; 23(3):353-363. PubMed ID: 36701814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Using FreeStyle Libre: A Retrospective Chart Review.
    Al Hayek AA; Al Dawish MA
    Adv Ther; 2021 Jun; 38(6):3314-3324. PubMed ID: 34009604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System
    Palacios A; Rodriguez-Cairoli F; Balan D; Rojas-Roque C; Moreno-López C; Braun B; Augustovski F; Pichon-Riviere A; Bardach A
    Appl Health Econ Health Policy; 2023 Jul; 21(4):637-650. PubMed ID: 37062046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.
    Nathanson D; Svensson AM; Miftaraj M; Franzén S; Bolinder J; Eeg-Olofsson K
    Diabetologia; 2021 Jul; 64(7):1595-1603. PubMed ID: 33774713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
    Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
    BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes.
    Scott EM; Bilous RW; Kautzky-Willer A
    Diabetes Technol Ther; 2018 Mar; 20(3):180-188. PubMed ID: 29470094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium.
    Visser MM; Van Muylder A; Charleer S; Isitt JJ; Roze S; De Block C; Maes T; Vanhaverbeke G; Nobels F; Keymeulen B; Mathieu C; Luyten J; Gillard P; Verhaeghe N
    Diabetologia; 2024 Apr; 67(4):650-662. PubMed ID: 38236409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Economic Burden of Insulin-Related Hypoglycemia in Spain.
    Parekh W; Hoskins N; Baker-Knight J; Ramirez de Arellano A; Mezquita Raya P
    Diabetes Ther; 2017 Aug; 8(4):899-913. PubMed ID: 28653237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on variables of severe hypoglycaemia and healthcare costs of the use of the FreeStyle system in paediatric population with type 1 diabetes mellitus.
    Leiva-Gea I; Porcel Chacón R; Ariza Jiménez AB; Mora Loro M; Tapia-Ceballos L; Jiménez-Hinojosa J; Gómez Perea A; López Siguero JP
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Oct; 69(8):561-565. PubMed ID: 36347794
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.